Europäische Arzneimittelagentur (EMA) – der Impfstoff von AstraZeneca soll in Zukunft den Markennamen Vaxzevria tragen
This entry was posted on Dienstag, April 6th, 2021 at 09:14 and is filed under Administration. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.